Last reviewed · How we verify
NCT03729882
Primary EUS-GBD in Patients With Unresectable Malignant Biliary Obstruction and Cystic Duct Orifice Involvement.
NA trial testing EUS-guided gallbladder drainage in Acute Cholecystitis in 22 participants. Completed in 27 July 2020.
27 December 2019
Quick facts
| Lead sponsor | Instituto Ecuatoriano de Enfermedades Digestivas |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 22 |
| Start date | 1 July 2018 |
| Primary completion | 27 December 2019 |
| Estimated completion | 27 July 2020 |
| Sites | 1 location across Ecuador |
Drugs / interventions tested
- EUS-guided gallbladder drainage
- Non EUS-guided gallbladder drainage
Conditions studied
- Acute Cholecystitis — all drugs for Acute Cholecystitis →
Sponsor
Instituto Ecuatoriano de Enfermedades Digestivas — full company profile →
Who can join
18 and older, any sex, with Acute Cholecystitis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
to determine if primary prophylaxis with Endoscopic Ultrasound-Gallbladder Drainage (EUS-GBD) in unresectable cancer patients with the orifice of the cystic duct (OCD) involvement is superior to conservative management (Non EUS-guided gallbladder drainage).
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
UEG Week 2019 Poster Presentations.
· 2019 · cited 5× · PMID 32213001 · DOI 10.1177/2050640619854671
Verify or expand the search:
- PubMed search for NCT03729882
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Acute Cholecystitis
Currently open trials in the same condition.
- NCT07161960 — Early Versus Delayed Cholecystectomy After Percutaneous Cholecystostomy in Moderate and Severe Cholecystitis (ESCAPE) · NA · recruiting
- NCT06967597 — Conservative Versus Proactive Management of Acute Cholecystitis After EUS-guided Transmural Gallbladder Drainage: FUGITI · NA · recruiting
- NCT07006298 — One-year Outcomes by Index Treatment in Elderly Patients With Acute Cholecystitis · recruiting
- NCT06287112 — Prevention of Acute Cholecystitis With ETGBD · NA · recruiting
- NCT05732480 — Influence of Gut Microbiome in Gallstone Disease · recruiting
Other Instituto Ecuatoriano de Enfermedades Digestivas trials
Trials by the same sponsor.
- NCT05453292 — Endoscopic Ultrasound Radiofrequency Ablation for GISTs · NA · unknown
- NCT06298604 — Motorized Fine Needle Biopsy vs Standard Needles · NA · unknown
- NCT06264466 — Safety and Efficacy of a Novel Flexible Bipolar in POEM · NA · unknown
- NCT06102980 — Endoscopic Ultrasound Shear Wave for Liver Fibrosis in MASLD Patients: The RUMIPAMBA Trial · NA · recruiting
- NCT06038201 — Cholecystectomy vs EUS-guided GBD With Stone Removal · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03729882 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Instituto Ecuatoriano de Enfermedades Digestivas
- Last refreshed: 28 July 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03729882.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing